Overview

Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort. Panic disorder often has a chronic course, its frequency and severity can be irregular, various physical, mental, and behavioral symptoms can develop, and the quality of life of individuals can decrease significantly. Evidence-based psychotherapy and pharmacotherapy are effective in reducing the symptoms of panic disorder and managing the disorder. However, both of these treatment methods have certain limitations, and approximately one-third of patients do not respond to therapy or the response is not sufficiently effective. Delaying treatment of the disease results in a poor prognosis and more established symptoms. Exercise can be viewed as a low-cost, supportive treatment for relieving symptoms with comparable efficacy to medication and other psychological interventions. Although exercise is recommended for patients with anxiety-panic disorder, there remains uncertainty about whether its effects are sustainable, the type and intensity of exercise required for effective treatment, and thus the effects of qigong and multicomponent exercise on multiple health outcomes in panic disorder. The aim of this study is to examine the effects of Qigong exercise training and multicomponent exercise training on anxiety-panic, balance, mobility, walking, functional strength, physical activity, sleep quality, fatigue, chronic musculoskeletal pain, quality of life and cognition.

Eligibility

Inclusion Criteria:

• Being between the ages of 18-65
• Being diagnosed with "panic disorder" by a psychiatrist
• Not having another psychiatric illness
• Wanting to participate in the research voluntarily and signing the informed consent
• Not having a history of communication or neuromusculoskeletal disease that would not allow the application of evaluation and treatment methods

Exclusion Criteria:

• Having a vision and/or hearing problem that would prevent participation in the study
• History of neurological, cardiopulmonary and musculoskeletal system disease that would negatively affect participation in evaluation and treatment